Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current management of interstitial cystitis.

James Chivian Lukban1, Kristene E Whitmore, Grannum R Sant

  • 1Graduate Hospital, 1800 Lombard Street, Pepper Pavilion, Suite 900, Philadelphia, PA 19146, USA. jlukban@aol.com

The Urologic Clinics of North America
|December 13, 2002
PubMed
Summary

Managing interstitial cystitis (IC) is challenging due to a lack of universally effective treatments. Current FDA-approved options like DMSO and PPS, alongside emerging therapies and sacral nerve stimulation, offer hope for symptom resolution.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gynecologic Manifestations of Interstitial Cystitis/Bladder Pain Syndrome.

International journal of urology : official journal of the Japanese Urological Association·2026
Same author

Role of Gynecologic Findings in Interstitial Cystitis/Bladder Pain Syndrome: A Consensus.

Neurourology and urodynamics·2025
Same author

Reply by Authors.

Urology practice·2025
Same author

Algorithm-Based Mobile Texting Platform for the Self-Management of Interstitial Cystitis/Bladder Pain Syndrome: Pilot Study Evaluating Feasibility, Usability, and Potential Utility.

Urology practice·2024
Same author

Clinical use of nadofaragene firadenovec-vncg.

Therapeutic advances in urology·2024
Same author

Mechanism of action of nadofaragene firadenovec-vncg.

Frontiers in oncology·2024

Area of Science:

  • Urology
  • Nephrology
  • Gastroenterology

Background:

  • Interstitial cystitis (IC) presents a significant clinical challenge.
  • No single therapeutic agent has demonstrated universal efficacy for IC management.
  • Current treatment strategies require careful consideration and sequential application.

Purpose of the Study:

  • To review current and emerging treatment options for interstitial cystitis (IC).
  • To discuss the efficacy and evaluation status of various IC therapeutic agents.
  • To outline a rational approach to IC management.

Main Methods:

  • Review of placebo-controlled trials for DMSO and PPS.
  • Discussion of ongoing clinical evaluations for BCG and hyaluronic acid.
  • Assessment of early results for sacral nerve root stimulation.

Related Experiment Videos

Main Results:

  • DMSO and PPS are FDA-approved treatments for IC, with prior placebo-controlled trial data.
  • BCG and hyaluronic acid are currently undergoing rigorous clinical evaluation.
  • Sacral nerve root stimulation shows promising early outcomes.

Conclusions:

  • A stepwise, time-dependent treatment algorithm is recommended for IC.
  • Adequate trial periods for successive therapies are crucial.
  • Timely symptom resolution should guide the pace of treatment adjustments.